Michael Logerfo has been appointed president of Sagent Pharmaceuticals, Inc. Mr. Logerfo will lead the executive management committee, with primary responsibility for the company’s strategic business development and legal functions. He reports to the chairman of the board, Frank Kung.
 
Mr. Logerfo has served as executive vice president and chief legal officer of Sagent since March 2012. He also served as corporate vice president, chief legal officer since, and secretary at the company. Prior to that, he was chief operating officer of the former KSCP joint venture, now Sagent (China) Pharmaceuticals (SCP).
 
“Michael has been an integral part of Sagent’s management team since very early in the company’s history,” said Mr. Kung. “He has played a significant role in the evolution of our unique business model and has developed strong relationships across our supply chain. Michael has been instrumental in advancing many key strategic initiatives and driving the profitable growth of the business. I look forward to working with Michael and the rest of the team as we pursue the next stage of Sagent’s corporate evolution.”